1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. NEUROVASCULAR INTERVENTION MARKET BY SPECIALTY TYPE
4.1. Introduction
4.2. Neurology
4.3. Neurosurgery
4.4. Neuroradiology
5. NEUROVASCULAR INTERVENTION MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Wires & Coils
5.3. Catheters
5.4. Balloons
5.5. Stents
5.6. Others
6. NEUROVASCULAR INTERVENTION MARKET BY DISEASE TYPE
6.1. Introduction
6.2. Arteriovenous Malformation
6.3. Arteriovenous Fistula
6.4. Brain Aneurysm
6.5. Others
7. NEUROVASCULAR INTERVENTION MARKET BY END-USERS
7.1. Introduction
7.2. Hospital
7.3. Ambulatory Surgical Centers
8. NEUROVASCULAR INTERVENTION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. Spain
8.4.3. United Kingdom
8.4.4. France
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. South Korea
8.6.4. India
8.6.5. Indonesia
8.6.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Mergers, Acquisitions, Agreements, and Collaborations
9.3. Vendor Matrix
10. COMPANY PROFILES
10.1. TE Connectivity
10.2. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD
10.3. Stryker Corporation
10.4. MicroPort
10.5. Terumo Corporation
10.6. Japan Lifeline Co., Ltd
10.7. Medtronic
10.8. Balt Group
10.9. NeuroSafe Medical Co., Ltd
10.10. ASAHI INTECC CO., LTD.
10.11. Philips
10.12. Integer Holdings Corporation
10.13. CERENOVUS (Johnson & Johnson)